These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11235170)

  • 1. [Genetic analysis of endometriosis and ovarian cancer].
    Obata K; Hoshiai H
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():217-20. PubMed ID: 11235170
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common genetic changes between endometriosis and ovarian cancer.
    Obata K; Hoshiai H
    Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An approach to early genetic alterations in precancerous cells].
    Sato N; Nishida M; Noguchi M
    Hum Cell; 2000 Sep; 13(3):103-8. PubMed ID: 11197771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
    Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
    Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correspondence re: W.M. Lin et al., loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin. Cancer Res., 4: 2577-2583, 1998.
    Matias-Guiu X; Bussaglia E; Catasus L; Lagarda H; Gras E; Machin P; Prat J
    Clin Cancer Res; 2000 Apr; 6(4):1598-600. PubMed ID: 10778994
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
    Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
    Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
    Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
    Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of ovarian cancer.
    Sanseverino F; D'Andrilli G; Petraglia F; Giordano A
    Anal Quant Cytol Histol; 2005 Jun; 27(3):121-4. PubMed ID: 16121632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ovarian cancers complicated by endometriosis].
    Obata K; Koike H; Shiina M
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():615-22. PubMed ID: 15535319
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of p53 mutation in the carcinomas arising from endometriosis.
    Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
    Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The malignant potential of ovarian atypical endometriosis].
    Guo L; Liu T; Lang J
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):169-72. PubMed ID: 11866970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometriosis-associated Ovarian Cancers.
    Anglesio MS; Yong PJ
    Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.
    Prowse AH; Manek S; Varma R; Liu J; Godwin AK; Maher ER; Tomlinson IP; Kennedy SH
    Int J Cancer; 2006 Aug; 119(3):556-62. PubMed ID: 16506222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic defects in endometriosis.
    Thomas EJ; Campbell IG
    Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mutation and expression of PTEN gene mRNA on tumorigenesis and progression of epithelial ovarian cancer.
    Chen Y; Zheng H; Yang X; Sun L; Xin Y
    Chin Med Sci J; 2004 Mar; 19(1):25-30. PubMed ID: 15104221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometriosis-associated ovarian carcinomas.
    Nissenblatt M
    N Engl J Med; 2011 Feb; 364(5):482-3; author reply 484-5. PubMed ID: 21288105
    [No Abstract]   [Full Text] [Related]  

  • 20. Endometriosis and the neoplastic process.
    Varma R; Rollason T; Gupta JK; Maher ER
    Reproduction; 2004 Mar; 127(3):293-304. PubMed ID: 15016949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.